Home > Qtrly Results > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Quarterly Results Analysis [Dec2023]

SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹65 Cr ₹64 Cr ₹60 Cr ₹61 Cr ₹57 Cr ₹54 Cr ₹51 Cr ₹58 Cr
Expenses ₹58 Cr ₹57 Cr ₹53 Cr ₹55 Cr ₹51 Cr ₹50 Cr ₹48 Cr ₹56 Cr
Operating Income ₹7 Cr ₹6 Cr ₹6 Cr ₹6 Cr ₹6 Cr ₹4 Cr ₹3 Cr ₹2 Cr
Other Income ₹5 Cr ₹4 Cr ₹2 Cr ₹7 Cr ₹2 Cr ₹3 Cr ₹3 Cr ₹6 Cr
Interest ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹9 Cr ₹8 Cr ₹6 Cr ₹10 Cr ₹6 Cr ₹5 Cr ₹5 Cr ₹6 Cr
Profit After Tax ₹7 Cr ₹7 Cr ₹4 Cr ₹8 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹5 Cr
EPS ₹0.07 ₹0.07 ₹0.05 ₹0.09 ₹0.04 ₹0.04 ₹0.04 ₹0.06
Industry Peers & Returns1W1M1Y
SYNCOM FORMULATIONS (INDIA) 4.5% 15.8% 126.6%
SUN PHARMACEUTICAL INDUSTRIES -2.3% -6.5% 55.3%
CIPLA 4.1% -4.8% 55.6%
DR REDDYS LABORATORIES 4% 0.8% 29.4%
ZYDUS LIFESCIENCES -1.2% -5.2% 83.9%
DIVIS LABORATORIES 7.8% 17.4% 20.3%
MANKIND PHARMA 1.3% 7% NA
TORRENT PHARMACEUTICALS 3.9% 5.1% 66.1%
LUPIN 0.6% 0.5% 127.2%

SYNCOM FORMULATIONS (INDIA) Quarterly Revenues

Revenues
Q-o-Q

2.04 %

Y-o-Y

13.52 %

Quarters Revenues % Change
Dec2023 ₹65 Cr
2.04
Sep2023 ₹64 Cr
6.69
Jun2023 ₹60 Cr
-1.87
Mar2023 ₹61 Cr
6.27
Dec2022 ₹57 Cr
5.31
Sep2022 ₹54 Cr
6.01
Jun2022 ₹51 Cr
-11.73
Mar2022 ₹58 Cr -

SYNCOM FORMULATIONS (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

14.86 %

Y-o-Y

24.60 %

Quarters Operating Profit % Change
Dec2023 ₹7 Cr
14.86
Sep2023 ₹6 Cr
-0.84
Jun2023 ₹6 Cr
8.41
Mar2023 ₹6 Cr
0.91
Dec2022 ₹6 Cr
37.89
Sep2022 ₹4 Cr
22.90
Jun2022 ₹3 Cr
70.42
Mar2022 ₹2 Cr -
Operating Margins
Q-o-Q

12.55 %

Y-o-Y

9.82 %

Quarters Operating Margin% % Change
Dec2023 11.3%
12.55
Sep2023 10.04%
-7.04
Jun2023 10.8%
10.54
Mar2023 9.77%
-5.05
Dec2022 10.29%
30.92
Sep2022 7.86%
15.93
Jun2022 6.78%
93.16
Mar2022 3.51% -

SYNCOM FORMULATIONS (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

7.54 %

Y-o-Y

68.95 %

Quarters Profit After Tax % Change
Dec2023 ₹7 Cr
7.54
Sep2023 ₹7 Cr
48.10
Jun2023 ₹4 Cr
-48.10
Mar2023 ₹8 Cr
104.39
Dec2022 ₹4 Cr
15.43
Sep2022 ₹4 Cr
-7.11
Jun2022 ₹4 Cr
-18.75
Mar2022 ₹5 Cr -
PAT Margins
Q-o-Q

5.39 %

Y-o-Y

48.89 %

Quarters PAT Margin(%) % Change
Dec2023 10.75 %
5.39
Sep2023 10.2 %
38.78
Jun2023 7.35 %
-47.08
Mar2023 13.89 %
92.38
Dec2022 7.22 %
9.56
Sep2022 6.59 %
-12.37
Jun2022 7.52 %
-7.96
Mar2022 8.17 % -

SYNCOM FORMULATIONS (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

0.00 %

Y-o-Y

75.00 %

Quarters EPS % Change
Dec2023 ₹0.07
0.00
Sep2023 ₹0.07
40.00
Jun2023 ₹0.05
-44.44
Mar2023 ₹0.09
125.00
Dec2022 ₹0.04
0.00
Sep2022 ₹0.04
0.00
Jun2022 ₹0.04
-33.33
Mar2022 ₹0.06 -

You may also like the below Video Courses